Douglas Stevens
Nurse Practitioner · Canton, OHNPI 1013474824
Payments from drug & device makers
Across 130 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$340
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$314
- Indivior Inc.$287
- Teva Pharmaceuticals USA, Inc.$220
- Otsuka America Pharmaceutical, Inc.$178
- Vanda Pharmaceuticals Inc.$164
- plus $707 from 10 others
What the payments were for
- Food & beverage$2,211100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 19 | $340 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $314 |
| Indivior Inc. | 27 | $287 |
| Teva Pharmaceuticals USA, Inc. | 14 | $220 |
| Otsuka America Pharmaceutical, Inc. | 9 | $178 |
| Vanda Pharmaceuticals Inc. | 5 | $164 |
| E.r. Squibb & Sons, L.L.C. | 10 | $156 |
| Corium, LLC | 4 | $125 |
| Lundbeck LLC | 7 | $122 |
| Neurocrine Biosciences, Inc. | 7 | $111 |
| AbbVie | 5 | $102 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Orexo US, Inc. | 1 | $13 |
How this compares
$2,211 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 166 | $21,551 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $12,665 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $287 | $12,66525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Canton
- Amy HazelCanton$63K
- Kristin BarnesCanton$9K
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.